Education
SMFM Podcast: Congenital Toxoplasmosis Prevention
-
Register
- Non-member - Free!
- Regular (MFM) - Free!
- Resident - Free!
- Associate - Free!
- Associate - Fellow - Free!
- Medical Student - Free!
- Practice Professional - Free!
- Honorary - Free!
- Emeritus - Free!
- Affiliate - Free!
- Internal - Free!
- NPWH - Allied Affiliate Membership - Free!
Already registered?
Log in now.
Speaker: Dr. Laurent Mandelbrodt
Podcast recorded: March 2018
SMFM member, Dr. Laurent Mandelbrodt, discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
Key:
Complete
Next
Failed
Available
Locked
Congenital Toxoplasmosis Prevention
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin.
SMFM member, Dr. Laurent Mandelbrodt, discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.